Loss of Therapeutic Benefit Seen After Stopping Baricitinib in Type 1 Diabetes

MONDAY, Sept. 29, 2025 (HealthDay News) -- Two-year follow-up shows a loss of therapeutic benefit when baricitinib treatment is stopped in type 1 diabetes (T1D)